阅读说明：本技术 EOC315 Mod.I晶型化合物及其制备方法 (EOC315 Mod.I crystal-form compound and preparation method thereof ) 是由 李合亭 王德强 常伟 于洪瑞 邹晓明 于 2018-04-03 设计创作，主要内容包括：本发明涉及一种4-(4-氯苯胺基)-7-(2-甲氨基羰基-4-氧甲基)吡啶基呋喃并[2,3-d]哒嗪甲磺酸盐(EOC315)的Mod.I晶型化合物的制备方法、晶型表征及其药物用途。<Image he="549" wi="516" file="DDA0002230250320000011.GIF" imgContent="drawing" imgFormat="GIF" orientation="portrait" inline="no"></Image>(The present invention relates to a kind of 4- (4- chloroanilino) -7- (2- amino-carbonyl -4- oxygen methyl) pyridyl group furans simultaneously the preparation method of the Mod.I crystal-form compound of [2,3-d] pyridazine mesylate (EOC315), crystal form characterization and its medicinal usage.)